Antony C. Mattessich serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Antony C. Mattessich has executed 13 insider transactions totaling $770.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 20, 2024 involved receiving (via award) 10,500 shares valued at $0.
Antony C. Mattessich currently holds 10,500 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Antony C. Mattessich has been a net buyer of OCUL stock. They have purchased $501.0K and sold $269.6K worth of shares.
Antony C. Mattessich's most recent insider trade was on Jun 20, 2024, when they sold 10,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.86 |
| Discretionary |
| Feb 3, 2024 | OCUL | $0 | Award | 180,400 | $N/A | Discretionary |
| Jan 31, 2024 | OCUL | $90.8K | Sale | 18,338 | $4.95 | Discretionary |
| Aug 30, 2023 | OCUL | $24.8K | Purchase | 6,500 | $3.81 | Discretionary |
| Feb 6, 2023 | OCUL | $83.4K | Sale | 19,669 | $4.24 | Discretionary |
| Jan 30, 2023 | OCUL | $0 | Award | 176,300 | $N/A | Discretionary |
| Feb 3, 2022 | OCUL | $0 | Award | 186,750 | $N/A | Discretionary |
| Aug 20, 2021 | OCUL | $49.5K | Purchase | 5,000 | $9.89 | Discretionary |
| Jun 6, 2019 | OCUL | $112.4K | Purchase | 40,000 | $2.81 | Discretionary |
| Aug 20, 2018 | OCUL | $119.0K | Purchase | 20,000 | $5.95 | Discretionary |
| Aug 10, 2018 | OCUL | $105.3K | Purchase | 16,900 | $6.23 | Discretionary |
| Dec 12, 2017 | OCUL | $90.1K | Purchase | 21,000 | $4.29 | Discretionary |